The microenvironment in T-cell lymphomas: Emerging themes

Seminars in Cancer Biology

Volumn 24, Issue , 2014, Pages 49-60

  Gaulard, Philippe ^a,b,c   de Leval, Laurence ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM U955   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiogenesis; Angioimmunoblastic T cell lymphoma; Folliclar helper T cell; Macrophages; Microenvironment; T cell lymphoma

Indexed keywords

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER PROGNOSIS; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; DISEASE COURSE; EOSINOPHILIA; GENETIC HETEROGENEITY; GENOME ANALYSIS; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; MACROPHAGE FUNCTION; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL T CELL LYMPHOMA; REVIEW; T CELL LYMPHOMA; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANGIOGENESIS; ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA; FOLLICLAR HELPER T CELL; MACROPHAGES; MICROENVIRONMENT; T-CELL LYMPHOMA;

HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, PERIPHERAL; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR MICROENVIRONMENT;

EID: 84892863011     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.11.004     Document Type: Review

References (118)

1. Armitage J., Vose J., Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008, 26:4124-4130.
2. Swerdlow S., Campo E., Harris N., Jaffe E., Pileri S., Stein H., et al. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, IARC Press, Lyon.
3. de Leval L., Rickman D.S., Thielen C., Reynies A., Huang Y.L., Delsol G., et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007, 109:4952-4963.
4. Travert M., Huang Y., de Leval L., Martin-Garcia N., Delfau-Larue M.H., Berger F., et al. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood 2012, 119:5795-5806.
5. Garcia-Herrera A., Song J.Y., Chuang S.S., Villamor N., Colomo L., Pittaluga S., et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 2011, 35:1214-1225.
6. Huang Y., de Reynies A., de Leval L., Ghazi B., Martin-Garcia N., Travert M., et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 2010, 115:1226-1237.
7. Frizzera G., Moran E., Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinemia. Lancet 1974, i:1070-1073.
8. Lukes R.J., Tindle B.H. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975, 292:1-8.
9. Lennert K. Nature, prognosis and nomenclature of angioimmunoblastic (lymphadenopathy (lymphogranulomatosis X or T-zone lymphoma). Dtsch Med Wochenschr 1979, 104:1246-1247.
10. Shimoyama M., Minato K. Clinical, cytological and immunological analysis of T-cell type lymphoid malignancies: a classification of T-cell type lymphoid malignancy (author's transl). Rinsho Ketsueki 1979, 20:1056-1069.
11. Weiss L., Strickler J., Dorfman R., Horning S., Warnke R., Sklar J. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol 1986, 122:392-397.
12. Kaneko Y., Maseki N., Sakurai M., Takayama S., Nanba K., Kikuchi M., et al. Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive angioimmunoblastic lymphadenopathy with dysproteinemia-type features. Blood 1988, 72:413-421.
13. Tobinai K., Minato K., Ohtsu T., Mukai K., Kagami Y., Miwa M., et al. Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood 1988, 72:1000-1006.
14. Feller A., Griesser H., Schilling C., Wacker H., Dallenbach F., Bartels H., et al. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol 1988, 133:549-556.
15. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392.
16. Jaffe E., Harris N., Stein H., Vardiman J. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues 2001, IARC Press, Lyon.
17. Rudiger T., Weisenburger D.D., Anderson J.R., Armitage J.O., Diebold J., MacLennan K.A., et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002, 13:140-149.
18. Parrens M., Martin A., Lamant L., Delarue R., Haioun C., Tournilhac O., et al. Angioimmunoblastic T-Cell lymphoma (AITL) is the most prevalent T-cell lymphoma entity in Western Europe. Blood 2012, 120:1607.
19. Mourad N., Mounier N., Briere J., Raffoux E., Delmer A., Feller A., et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2008, 111:4463-4470.
20. Federico M., Rudiger T., Bellei M., Nathwani B.N., Luminari S., Coiffier B., et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol 2013, 31:240-246.
21. Baseggio L., Berger F., Morel D., Delfau-Larue M.H., Goedert G., Salles G., et al. Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma. Leukemia 2006, 20:296-303.
22. Baseggio L., Traverse-Glehen A., Berger F., Ffrench M., Jallades L., Morel D., et al. CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma. Mod Pathol 2011, 24:993-1003.
23. Ree H.J., Kadin M.E., Kikuchi M., Ko Y.H., Go J.H., Suzumiya J., et al. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol 1998, 22:643-655.
24. Attygalle A., Al-Jehani R., Diss T.C., Munson P., Liu H., Du M.Q., et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002, 99:627-633.
25. Grogg K.L., Attygalle A.D., Macon W.R., Remstein E.D., Kurtin P.J., Dogan A. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cellsα. Blood 2005, 106:1501-1502.
26. Dupuis J., Boye K., Martin N., Copie-Bergman C., Plonquet A., Fabiani B., et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006, 30:490-494.
27. Grogg K.L., Attygale A.D., Macon W.R., Remstein E.D., Kurtin P.J., Dogan A. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006, 19:1101-1107.
28. Ortonne N., Dupuis J., Plonquet A., Martin N., Copie-Bergman C., Bagot M., et al. Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). Am J Surg Pathol 2007, 31:1068-1076.
29. Piccaluga P.P., Agostinelli C., Califano A., Carbone A., Fantoni L., Ferrari S., et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007, 67:10703-10710.
30. McHeyzer-Williams L.J., Pelletier N., Mark L., Fazilleau N., McHeyzer-Williams M.G. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 2009, 21:266-273.
31. Vinuesa C.G., Tangye S.G., Moser B., Mackay C.R. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 2005, 5:853-865.
32. Fazilleau N., Mark L., McHeyzer-Williams L.J., McHeyzer-Williams M.G. Follicular helper T cells: lineage and location. Immunity 2009, 30:324-335.
33. Gaulard P., de Leval L. Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol 2011, 28:202-213.
34. Bisig B., Thielen C., Herens C., Gofflot S., Travert M., Delfau-Larue M.H., et al. c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis. Histopathology 2012, 60:371-376.
35. Attygalle A.D., Chuang S.S., Diss T.C., Du M.Q., Isaacson P.G., Dogan A. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007, 50:498-508.
36. Karube K., Aoki R., Nomura Y., Yamamoto K., Shimizu K., Yoshida S., et al. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases. Pathol Int 2008, 58:89-97.
37. Boulland M.L., Kanavaros P., Wechsler J., Casiraghi O., Gaulard P. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. J Pathol 1997, 183:432-439.
38. de Leval L., Gisselbrecht C., Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2010, 148:673-689.
39. Nagoshi H., Kuroda J., Kobayashi T., Maegawa S., Chinen Y., Kiyota M., et al. Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis. Int J Hematol 2013, 98:366-374.
40. Ahsanuddin A.N., Brynes R.K., Li S. Peripheral blood polyclonal plasmacytosis mimicking plasma cell leukemia in patients with angioimmunoblastic T-cell lymphoma: report of 3 cases and review of the literature. Int J Clin Exp Pathol 2011, 4:416-420.
41. Huppmann A.R., Roullet M.R., Raffeld M., Jaffe E.S. Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. J Clin Oncol 2013, 31:e28-e30.
42. Papadi B., Polski J.M., Clarkson D.R., Liu-Dumlao T.O. Atypical angioimmunoblastic T-cell lymphomas masquerading as systemic polyclonal B-immunoblastic proliferation. Virchows Arch 2012, 461:323-331.
43. Sato F., Ishida T., Ito A., Mori F., Masaki A., Takino H., et al. Angioimmunoblastic T-cell lymphoma mice model. Leuk Res 2013, 37:21-27.
44. Foss H.D., Anagnostopoulos I., Herbst H., Grebe M., Ziemann K., Hummel M., et al. Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1995, 85:2862-2869.
45. Zhao W.L., Mourah S., Mounier N., Leboeuf C., Daneshpouy M.E., Legres L., et al. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest 2004, 84:1512-1519.
46. Fukushima N., Satoh T., Sano M., Tokunaga O. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 2001, 42:709-720.
47. Tripodo C., Gri G., Piccaluga P.P., Frossi B., Guarnotta C., Piconese S., et al. Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. Am J Pathol 2010, 177:792-802.
48. Konstantinou K., Yamamoto K., Ishibashi F., Mizoguchi Y., Kurata M., Nakagawa Y., et al. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. Br J Haematol 2009, 144:696-704.
49. Thielen C., Radermacher V., Trimeche M., Roufosse F., Goldman M., Boniver J., et al. TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res 2008, 32:1431-1438.
50. Ohshima K.S., Suzumiya J., Kawasaki C., Kanda M., Kikuchi M. Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 2000, 38:541-545.
51. Patsouris E., Noel H., Lennert K. Angioimmunoblastic lymphadenopathy-type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma. Am J Surg Pathol 1989, 13:262-275.
52. Niino D., Komohara Y., Murayama T., Aoki R., Kimura Y., Hashikawa K., et al. Ratio of M2 macrophage expression is closely associated with poor prognosis for angioimmunoblastic T-cell lymphoma (AITL). Pathol Int 2010, 60:278-283.
53. Pizzolo G., Vinante F., Agostini C., Zambello R., Trentin L., Masciarelli M., et al. Immunologic abnormalities in angioimmunoblastic lymphadenopathy. Cancer 1987, 60:2412-2418.
54. Delfau-Larue M.H., de Leval L., Joly B., Plonquet A., Challine D., Parrens M., et al. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. Haematologica 2012, 97:1594-1602.
55. Bruneau J., Canioni D., Renand A., Marafioti T., Paterson J.C., Martin-Garcia N., et al. Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol 2010, 177:570-574.
56. Attygalle A., Cabeçadas J., Gaulard P., Jaffe E., dJ D., Ko Y., et al. Peripheral T- and NK-cell lymphomas and their mimics: taking a step forward - report on the Lymphoma Workshop of the XVI meeting of the European Association for Haematopathology in Lisbon 2012. Histopathology 2014, 64:171-199.
57. Nicolae A., Pittaluga S., Venkataraman G., Vijnovich-Baron A., Xi L., Raffeld M., et al. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol 2013, 37:816-826.
58. Attygalle A.D., Kyriakou C., Dupuis J., Grogg K.L., Diss T.C., Wotherspoon A.C., et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007, 31:1077-1088.
59. Zettl A., Lee S.S., Rudiger T., Starostik P., Marino M., Kirchner T., et al. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002, 117:368-379.
60. Willenbrock K., Brauninger A., Hansmann M.L. Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 2007, 138:733-739.
61. Brauninger A., Spieker T., Willenbrock K., Gaulard P., Wacker H.H., Rajewsky K., et al. Survival and clonal expansion of mutating forbidden (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T-cell lymphoma. J Exp Med 2001, 194:927-940.
62. Lome-Maldonado C., Canioni D., Hermine O., Delabesse E., Damotte D., Raffoux E., et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TLα. Leukemia 2002, 16:2134-2141.
63. Tan B.T., Warnke R.A., Arber D.A. The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 2006, 8:466-475. [quiz 527].
64. de Leval L., Bisig B., Thielen C., Boniver J., Gaulard P. Molecular classification of T-cell lymphomas. Crit Rev Oncol Hematol 2009.
65. Dogan A., Attygalle A.D., Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003, 121:681-691.
66. Murakami Y.I., Yatabe Y., Sakaguchi T., Sasaki E., Yamashita Y., Morito N., et al. c-Maf expression in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2007, 31:1695-1702.
67. Lemonnier F., Couronne L., Parrens M., Jais J.P., Travert M., Lamant L., et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 2012, 120:1466-1469.
68. Cairns R.A., Iqbal J., Lemonnier F., Kucuk C., de Leval L., Jais J.P., et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 2012, 119:1901-1903.
69. Couronne L., Bastard C., Bernard O.A. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med 2012, 366:95-96.
70. Guo s, Kucuk C., Iqbal J., Rohr J., Bi C., Wang C., et al. Novel fusion transcripts identified in angioimmunoblastic T cell lymphoma. Mod Pathol 2013, 26:330A.
71. Ellyard J.I., Chia T., Rodriguez-Pinilla S.M., Martin J.L., Hu X., Navarro-Gonzalez M., et al. Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice. Blood 2012, 120:812-821.
72. Auguste T., Travert M., Tarte K., Ame-Thomas P., Artchounin C., Martin-Garcia N., et al. ROQUIN/RC3H1 alterations are not found in angioimmunoblastic T-cell lymphoma. PLoS ONE 2013, 8:e64536.
73. Beachy S.H., Onozawa M., Chung Y.J., Slape C., Bilke S., Francis P., et al. Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma. Blood 2012, 120:1048-1059.
74. Iqbal J., Weisenburger D.D., Greiner T.C., Vose J.M., McKeithan T., Kucuk C., et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010, 115:1026-1036.
75. Tokunaga T., Shimada K., Yamamoto K., Chihara D., Ichihashi T., Oshima R., et al. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan. Blood 2012, 119:2837-2843.
76. Dullaers M., Li D., Xue Y., Ni L., Gayet I., Morita R., et al. A T cell-dependent mechanism for the induction of human mucosal homing immunoglobulin A-secreting plasmablasts. Immunity 2009, 30:120-129.
77. Carbone A., Gloghini A., Cabras A., Elia G. The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol 2009, 145:468-480.
78. Klein U., Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008, 8:22-33.
79. de Leval L., Savilo E., Longtine J., Ferry J.A., Harris N.L. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol 2001, 25:395-400.
80. Huang Y., Moreau A., Dupuis J., Streubel B., Petit B., Le Gouill S., et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 2009, 33:682-690.
81. Moroch J., Copie-Bergman C., de Leval L., Plonquet A., Martin-Garcia N., Delfau-Larue M.H., et al. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol 2012, 36:1636-1646.
82. Streubel B., Vinatzer U., Willheim M., Raderer M., Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006, 20:313-318.
83. Pechloff K., Holch J., Ferch U., Schweneker M., Brunner K., Kremer M., et al. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med 2010, 207:1031-1044.
84. Rodriguez Pinilla S.M., Roncador G., Rodriguez-Peralto J.L., Mollejo M., Garcia J.F., Montes-Moreno S., et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009, 33:81-90.
85. Quintanilla-Martinez L., Jansen P.M., Kinney M.C., Swerdlow S.H., Willemze R. Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol 2013, 139:491-514.
86. Lamant L., McCarthy K., d'Amore E., Klapper W., Nakagawa A., Fraga M., et al. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J Clin Oncol 2011, 29:4669-4676.
87. Geissinger E., Odenwald T., Lee S.S., Bonzheim I., Roth S., Reimer P., et al. Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch 2004, 445:334-343.
88. Patsouris E., Engelhard M., Zwingers T., Lennert K. Lymphoepithelioid cell lymphoma (Lennert's lymphoma): clinical features derived from analysis of 108 cases. Br J Haematol 1993, 84:346-348.
89. Ballester B., Ramuz O., Gisselbrecht C., Doucet G., Loi L., Loriod B., et al. Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 2006, 25:1560-1570.
90. Cuadros M., Dave S.S., Jaffe E.S., Honrado E., Milne R., Alves J., et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 2007, 25:3321-3329.
91. Zhang W., Wang L., Zhou D., Cui Q., Zhao D., Wu Y. Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified. Leuk Lymphoma 2011, 52:46-52.
92. Kimura H., Ito Y., Kawabe S., Gotoh K., Takahashi Y., Kojima S., et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 2012, 119:673-686.
93. Allory Y., Challine D., Haioun C., Copie-Bergman C., Delfau-Larue M.H., Boucher E., et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am J Surg Pathol 2001, 25:865-874.
94. Lay J.D., Tsao C.J., Chen J.Y., Kadin M.E., Su I.J. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997, 100:1969-1979.
95. Chuang H., Lay J., Chuang S., Hsieh W., Chang Y., Su I. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. Am J Pathol 2007, 170:1607-1617.
96. Hayashi K., Ohara N., Teramoto N., Onoda S., Chen H.L., Oka T., et al. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am J Pathol 2001, 158:1533-1542.
97. Clementi R., Locatelli F., Dupre L., Garaventa A., Emmi L., Bregni M., et al. A proportion of patients with lymphoma may harbor mutations of the PERFORIN gene. Blood 2005, 105:4424-4428.
98. Kinney M.C., Higgins R.A., Medina E.A. Anaplastic large cell lymphoma: twenty-five years of discovery. Arch Pathol Lab Med 2011, 135:19-43.
99. Teruya-Feldstein J., Jaffe E.S., Burd P.R., Kanegane H., Kingma D.W., Wilson W.H., et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997, 90:4099-4105.
100. Aggarwal D., Srivastava G., Gupta R., Pant L., Krishan G., Singh S. Angiogenesis in non-Hodgkin's lymphoma: an intercategory comparison of microvessel density. ISRN Hematol 2012, 2012:943089.
101. Rabenhorst A., Schlaak M., Heukamp L.C., Forster A., Theurich S., von Bergwelt-Baildon M., et al. Mast cells play a protumorigenic role in primary cutaneous lymphoma. Blood 2012, 120:2042-2054.
102. Rafii S., Lyden D., Benezra R., Hattori K., Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapyα. Nat Rev Cancer 2002, 2:826-835.
103. Tabbo F., Ponzoni M., Rabadan R., Bertoni F., Inghirami G. Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma. Curr Opin Hematol 2013, 20:374-381.
104. Salven P., Orpana A., Teerenhovi L., Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood 2000, 96:3712-3718.
105. Ganjoo K., Hong F., Horning S.J., Gascoyne R.D., Natkunam Y., Swinnen L.J., et al. Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leuk Lymphoma 2013, Jul 29 [Epub ahead of print].
106. Roufosse F., Garaud S., de Leval L. Lymphoproliferative disorders associated with hypereosinophilia. Semin Hematol 2012, 49:138-148.
107. Miyagaki T., Sugaya M., Fujita H., Ohmatsu H., Kakinuma T., Kadono T., et al. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol 2010, 130:2304-2311.
108. Kong Y.Y., Dai B., Kong J.C., Lu H.F., Shi D.R. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases. Histopathology 2009, 55:189-196.
109. Kleinhans M., Tun-Kyi A., Gilliet M., Kadin M.E., Dummer R., Burg G., et al. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 2003, 101:1487-1493.
110. Ionescu M.A., Rivet J., Daneshpouy M., Briere J., Morel P., Janin A. In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia. J Am Acad Dermatol 2005, 52:32-39.
111. Utsunomiya A., Ishida T., Inagaki A., Ishii T., Yano H., Komatsu H., et al. Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a significant unfavorable prognostic factor. Leuk Res 2007, 31:915-920.
112. Roufosse F., Cogan E., Goldman M. Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27:389-413.
113. Lacy P., Moqbel R. Eosinophil cytokines. Chem Immunol 2000, 76:134-155.
114. Narducci M.G., Scala E., Bresin A., Caprini E., Picchio M.C., Remotti D., et al. Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood 2006, 107:1108-1115.
115. Chandesris M.O., Malamut G., Verkarre V., Meresse B., Macintyre E., Delarue R., et al. Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives. Gastroenterol Clin Biol 2010, 34:590-605.
116. Teruya-Feldstein J., Setsuda J., Yao X., Kingma D.W., Straus S., Tosato G., et al. MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. Lab Invest 1999, 79:1583-1590.
117. Maruoka H., Inoue D., Takiuchi Y., Nagano S., Arima H., Tabata S., et al. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol 2013, Aug 25 [Epub ahead of print].
118. Mazodier K., Marin V., Novick D., Farnarier C., Robitail S., Schleinitz N., et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005, 106:3483-3489.